USNA · Usana Health Sciences Inc · Debt
$14.07
+0.03 (+0.21%)
At close · Oct 27
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$262.92M
Shares
18.48M
Volume · Oct 27
136.81K
Avg daily vol (3M)
205.85K
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current portion of line of credit borrowings | 2026-07-04 | USD 0 | 10-Q filed 2026-08-13 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
896264
CUSIP
90328M107
13F (30d)
19 filings
19 filers
Visit website
Investor relations